Silexion Therapeutics Corp (SLXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 58 | 35 | 72 | 60 | 202 |
| TOTAL | $86 | $76 | $113 | $104 | $327 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 5,585 | 27,405 | 26,847 | 116,692 | 115,699 |
| TOTAL | $5,585 | $27,405 | $26,847 | $116,692 | $115,699 |
| Total Assets | $5,671 | $27,481 | $26,960 | $116,796 | $116,027 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,491 | 2,140 | 1,605 | 1,190 | 1,010 |
| Accrued Expenses | 34 | 102 | 278 | 87 | 2 |
| TOTAL | $2,525 | $2,242 | $1,883 | $1,277 | $1,012 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 5,616 | 27,429 | 26,872 | 116,722 | 115,718 |
| TOTAL | $5,594 | $27,429 | $26,872 | $116,722 | $115,718 |
| Total Liabilities | $8,119 | $29,671 | $28,755 | $117,998 | $116,731 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29 | 44 | 44 | 44 | 110 |
| Retained earnings | -2,449 | -2,190 | -1,795 | -1,203 | -862 |
| TOTAL | $-2,448 | $-2,190 | $-1,795 | $-1,203 | $-704 |
| Total Liabilities And Equity | $5,671 | $27,481 | $26,960 | $116,796 | $116,027 |